pSSA-eGFP (pXK-221)
(Plasmid
#208826)
-
Purpose(Empty Backbone) The SSA-based surrogate reporter for validating the activity of gene editing tools as well as for helping to screen gene-editing positive cells. Key Construct: CAG-PuroR-CMV-eGFP*(SSA).
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 208826 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBlue
-
Vector typeMammalian Expression
- Promoter CMV
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSSA-eGFP (pXK-221) was a gift from Kun Xu (Addgene plasmid # 208826 ; http://n2t.net/addgene:208826 ; RRID:Addgene_208826) -
For your References section:
Efficient genome engineering in eukaryotes using Cas9 from Streptococcus thermophilus. Xu K, Ren C, Liu Z, Zhang T, Zhang T, Li D, Wang L, Yan Q, Guo L, Shen J, Zhang Z. Cell Mol Life Sci. 2015 Jan;72(2):383-99. doi: 10.1007/s00018-014-1679-z. Epub 2014 Jul 20. 10.1007/s00018-014-1679-z PubMed 25038777